METHODS	The VALIANT ( Valsartan In Acute Myocardial Infarction ) trial enrolled 14,703 patients post-MI complicated by Killip class II or higher ( scale measuring heart failure severity post-MI ranging from class I to IV ) and/or reduced ejection fraction .\